Lv1
24 积分 2025-04-02 加入
Liver disease: screening for the elusive adversary
1个月前
已完结
Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study
1个月前
已关闭
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration
1个月前
已完结
Immunotherapy of Hepatocellular Carcinoma
1个月前
已完结
Results from the MORPHEUS-liver study: Phase Ib/II randomized evaluation of tiragolumab (tira) in combination with atezolizumab (atezo) and bevacizumab (bev) in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (uHCC)
1个月前
已完结
P-61 Relatlimab + nivolumab in patients with advanced hepatocellular carcinoma who are naive to immuno-oncology therapy but progressed on tyrosine kinase inhibitors, a phase 2, randomized, open-label study: RELATIVITY-073
1个月前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
2个月前
已完结
Synthesis and in vitro evaluation of tetrahydroisoquinolines with pendent aromatics as sigma-2 (σ2) selective ligands
2个月前
已完结
Virtual screening using molecular simulations
3个月前
已完结
Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations
3个月前
已完结
皖公网安备34019202002308
